2023-03-03 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 30,240 0.0447% | $12.63 | $382,070 | -41.47% | |
2023-03-02 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 29,000 0.0425% | $12.37 | $358,588 | -40.65% | |
2023-02-02 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 5,000 0.0085% | $16.25 | $81,248 | -44.8% | |
2023-02-01 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 25,000 0.0369% | $16.75 | $418,675 | -53.24% | |
2023-01-04 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 15,000 0.0223% | $14.89 | $223,343 | -44.86% | |
2023-01-03 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 25,000 0.0378% | $15.25 | $381,213 | -45.12% | |
2022-04-21 | Sale | Aclaris Therapeutics, Inc. ACRS | President and CEO | 25,000 0.0379% | $15.04 | $376,098 | +0.73% | |
2022-03-11 | Sale | Aclaris Therapeutics, Inc. ACRS | President and CEO | 56,303 0.0923% | $15.91 | $896,045 | -1.71% | |
2022-02-09 | Sale | Aclaris Therapeutics, Inc. ACRS | President and CEO | 3,595 0.0058% | $12.66 | $45,513 | +22.76% | |
2021-06-02 | Sale | Aclaris Therapeutics, Inc. ACRS | President and CEO | 66,520 0.1227% | $21.64 | $1.44M | -30.08% | |
2021-04-22 | Sale | Aclaris Therapeutics, Inc. ACRS | President and CEO | 60,000 0.1115% | $26.84 | $1.61M | -40.38% | |
2018-04-05 | Aclaris Therapeutics, Inc. ACRS | President and CEO | 20,000 0.065% | $16.75 | $335,000 | -15.4% | ||
2014-05-07 | Aldeyra Therapeutics, Inc. ALDX | director | 12,500 0.4422% | $8.00 | $100,000 | +20.66% |